Go Deep
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -18,656 | -7.5 | -2.73 | 0.10 | 1,155.52 |
| Oct 2026 | -18,565 | -7.2 | -2.63 | 0.10 | 1,114.79 |
| Oct 2026 | -18,801 | -7.3 | -2.67 | 0.10 | 1,132.11 |
| Oct 2026 | -19,079 | -8.1 | -2.96 | 0.10 | 1,256.32 |
| Oct 2026 | -19,224 | -8.5 | -3.12 | 0.10 | 1,317.53 |
| Oct 2026 | -19,226 | -8.6 | -3.12 | 0.10 | 1,315.81 |
Obsidian Therapeutics, Inc. Quarterly Results
| Line Item | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -19,633,000.0 | -24,986,000.0 |
| EPS | -0.3 | -0.4 |
Obsidian Therapeutics, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -100,607,000.0 | -83,109,000.0 |
| EPS | -1.6 | -1.3 |
Obsidian Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 88,580,000.0 | 183,713,000.0 |
| Total Liabilities | 354,617,000.0 | 358,144,000.0 |
| Total Equity | -266,037,000.0 | -174,431,000.0 |
Owes vs Owns
Obsidian Therapeutics, Inc. owed $4.94 for every $1 it owned in Mar 2026, up from $1.95 in Dec 2024.
| Period | Mar 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 4.94× | 4.00× | 1.95× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Obsidian Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 90.9%Fixed assets (tangible) 6.8%Other assets 2.3%
How it's funded — Dec 2025
Short-term debt 0.9%Other liabilities 98.8%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 80.5 | 168.3 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 6.1 | 9.9 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 2.0 | 5.6 |
| Liabilities & equity | ||
| Short-term debt | 3.1 | 3.0 |
| Long-term debt | 1.2 | 3.8 |
| Payables | 0.0 | 1.8 |
| Other liabilities | 350.3 | 349.5 |
| Shareholders' equity | -266.0 | -174.4 |
| Net tangible assets | -266.0 | -174.4 |
Obsidian Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -90,393,000.0 | -75,002,000.0 |
| Investing Activities | 81,017,000.0 | -53,874,000.0 |
| Financing Activities | 20,000.0 | 162,515,000.0 |